MD Biosciences

MD Biosciences Neuro is a translational contract research organization specializing in pain and neurodegenerative disease models, including validated large animal models that support clinical translation. Founded in 1991, MD Biosciences brings more than three decades of preclinical research experience to its dedicated neuroscience practice, partnering with drug developers to generate the non-clinical evidence needed to advance non-opioid analgesics from discovery through IND enabling studies. Alongside client studies, MD Biosciences advances its own pipeline of proprietary assets.

With in house histology, biomarker analysis and electrophysiology, MD Biosciences works as an extension of its clients’ teams, designing custom studies in minipigs, domestic pigs, rodents and ex vivo and in vitro platforms that move programs through the development pipeline efficiently. Its 20,000 square foot GLP facility includes dedicated rodent and large animal labs and supports GLP toxicology and FDA submission.

MD Biosciences is accredited by AAALAC International, holds an NIH Office of Laboratory Animal Welfare Foreign Assurance, and is a signatory to the Marseille Declaration.